NVIDIA Unveils Proteina-Complexa for BioNeMo Research

NVIDIA announced Proteina-Complexa at the GTC 2026 conference to advance biomedical research ^[1]. This new generative model focuses on designing protein binders, which is a critical step in creating modern medicines ^[1][2]. The company also expanded its BioNeMo platform by releasing open datasets and advanced AI tools to help scientists ^[2][3]. The update includes a massive expansion of the AlphaFold database, which now features 30 million protein complex predictions ^[1]. These resources help researchers identify new drug targets more efficiently than traditional methods ^[2]. NVIDIA aims to support the next wave of healthcare AI through these open model families ^[1].